| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC1967 |
| Trial ID | NCT03664635 |
| Disease | B-Cell Lymphoma | Non-Hodgkin's Lymphoma |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MB-CAR-T20.1 |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | MB-CART20.1 Lymphoma |
| Year | 2018 |
| Country | Germany |
| Company sponsor | Miltenyi Biomedicine GmbH |
| Other ID(s) | M-2016-312 |
| Vector information | |||||
|
|||||
| Cohort1: dose level 1 | |||||||||||
|
|||||||||||
| Cohort2: dose level 2 | |||||||||||
|
|||||||||||
| Cohort3: dose level 3 | |||||||||||
|
|||||||||||